• Logo
  • SBMUJournals

Holmium Laser Prostate Enucleation (HOLEP) Versus Trans-Urethral Resection of Prostate (TURP) in Treatment of Symptomatic Prostatic Enlargement;A Health Technology Assessment

Sakineh Hajebrahimi, Alireza Mahboub Ahari, Fatemeh Sadeghi Ghyassi, Ali Mostafaie, Mahmoud Yousefi




INTRODUCTION: Our aim was to compare the cost effectiveness of holmium laser prostate enucleation (HOLEP) versus trans-urethral resection of prostate.

METHODS: We searched all available databases for any controlled trials comparing HOLEP and TURP from January 2000 to February 2009. Two independent reviewers studied and appraised the selected evidences. Then, effectiveness and cost effectiveness of HOLEP was evaluated.

RESULTS: We identified four randomized controlled trials and one systematic review according to the inclusion criteria. Most of the studies had moderate quality of evidence with limited sample sizes. Overall success rate of HOLEP was comparable with TURP; but, some secondary outcomes such as pick flow rate twelve months after the surgery was better in HOLEP. A comparison between the original costs and those obtained from sensitivity analysis showed that the cost parameters were sensitive to the number of the patients treated. Increasing the number of the patients from 200 to 300 changed the study’s results in favor of the new techniques.

CONCLUSION: Since the holmium and thulium laser sets are sensitive to the number of the patients and multipurpose, they potentially can be applied for stone fragmentation.Thus, utilization of these equipments will divide the costs between two groups of the services. In economic terms, these properties lower overhead costs and justify the purchasing of these equipments.


Lasers, Solid-State; Prostate; Holmium laser; Therapy; Symptomatic Prostatic Enlargement; Assessment, Biomedical Technology


Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int. 2006;97(s2):3-6.

Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003;92(4):409-14.

Fong YK, Milani S, Djavan B. Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. Curr Opin Urol 2005 Jan;15 (1):35-8.

Safarinejad MR. Prevalence of benign prostatic hyperplasia in a populationbased study in Iranian men 40 years old or older. Int Urol Nephrol 2008;40(4):921-31.

Basiri A, Mousavi SM, Naghavi M, Araghi IA, Namini SA. Urologic diseases in the Islamic Republic of Iran: what are the public health priorities?. East Mediterr Health J 2008;14(6):1406-16.

Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006 Jun;49(6):961-9.

Culyer AJ. The Dictionary of health economics. 2nd ed. Cheltenham: Edward Elgar; 2010.

Elliot R, Payne K. Essentials of economic evaluation in healthcare. Grayslake: Pharmaceutical Press; 2005.

Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL eds. Methods for economic evaluation of health care programs, 3rd ed. Oxford: Oxford University Press; 2005.

Muenning P. Cost effectiveness analysis in health: A practical approach, 2nd ed. San Francisco: Jossey- Bass; 2008.

Saba VK, Arnold JM. A clinical care costing method. Stud Health Technol Inform. 2004;107(Pt 2):1371-3.

In Fieschi M, Coiera E, Li YCJ, eds. Medinfo 2004: proceedings of the 11th 13. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20(7):443-54.

Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int. 2006 Jan;97(1):85-9.

Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate:a randomized prospective trial in 200 patients. J Urol 2004 Sep;172(3):1012-6.

Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004 Nov;172(5 Pt 1):1926-9.

Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol. 2004 Aug;172(2):616-9.

Wilson LC, Gilling P, Williams A, Kennett KM, Frampton CM, Westenberg AM et al. A randomised trial comparing holmium laser enucleation versus trnsurethral resectionin the treatment of prostates larger than 40 grams: resultsat 2 years. Eur Urol. 2006;50:569-73.

Lourenco T, Pickard R, Vale L, Grant A, Fraser C,MacLennan G et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematicreview of randomised controlled trials. BMJ. 2008 Jun 30;337:a449.

Dubey D, Muruganandham K. Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial. Indian J Urol. 2008 Jul;24(3):428-9.

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN.Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol.2008 Feb;53(2):382-89

DOI: https://doi.org/10.22037/jlms.v2i1.2159